HOME >> BIOLOGY >> NEWS
AAAS urges US President to sign Embryonic Stem Cell Act

The American Association for the Advancement of Science (AAAS), the world's largest general scientific organization, tonight urged U.S. President George W. Bush to uphold the U.S. Senate's approval of H.R. 810, the Stem Cell Research Enhancement Act.

"We in the scientific community are hopeful that you will review this measure with an open mind and open heart and then sign it into law," AAAS leadership wrote in the letter to President Bush.

The Stem Cell Research Enhancement Act, which would expand federal support for embryonic stem cell research, passed in the U.S. Senate by a vote of 63 to 37 four votes short of the two-thirds majority needed to override a presidential veto. The President has stated that he would veto the measure, but AAAS called on him to reconsider, noting that "embryonic stem cell research is an extremely promising approach to developing more effective treatments for devastating conditions like diabetes, spinal cord, injuries, and Parkinson's and Alzheimer's diseases."

Human blastocysts, or very early-stage human embryos, "appear by far to hold the greatest therapeutic promise" for advancing stem-cell research, AAAS officials wrote. While acknowledging the President's objections to creating and then destroying embryos explicitly for the purpose of deriving stem cells for research, AAAS Chairman of the Board Gilbert S. Omenn, M.D., Ph.D., and Chief Executive Officer Alan I. Leshner, Ph.D., noted that some 400,000 embryos, left over from in vitro fertilization techniques, would otherwise be discarded.

Further, Omenn and Leshner added, "H.R. 810 would enable the Federal government to exercise a higher level of regulation and ethical oversight over human embryonic stem cell research than it can now."

In closing, AAAS officials wrote: "We see H.R. 810 as an affirmation of life, and of the potential of scientific and medical research to improve the human condition. We are gratified to sta
'"/>

Contact: Ginger Pinholster
gpinhols@aaas.org
202-326-6421
American Association for the Advancement of Science
18-Jul-2006


Page: 1 2

Related biology news :

1. Contributing membership in the biomarkers consortium surges to 30 companies and nonprofits
2. APS President-Elect Carey urges 6.7 percent increase for biomedical research
3. Virginia study urges early emphasis on science
4. NIH panel urges more informed approach to multivitamin/mineral use for chronic disease prevention
5. New journal article urges use of animal serum-free media for growing live cells
6. US Surgeon General urges Americans to know their family health history
7. To stem disease, keep cats indoors, stop feeding strays, scientist urges
8. AAAS CEO Alan I. Leshner urges US to continue collecting job data on women workers
9. Study urges caution in contaminant source tracking
10. The CF Foundation urges all states to include newborn screening for cystic fibrosis in test panels
11. President Bush announces 2005 and 2006 Laureates of National Medals of Science and Technology

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: AAAS urges President sign Embryonic Stem Cell Act

(Date:3/10/2015)...  Continuing its 167-year history of offering the Best, ... The Eye Scanning Password Authenticator , a device that ... websites or sensitive data. Employing the same ... the device has a small camera that scans and ... converting them into an encrypted ID that cannot be ...
(Date:3/4/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/48tj8z/global_biometrics ) ... Biometrics Market Forecast and Opportunities, 2020" report ... biometric authentication systems is projected to grow at ... The driving forces for this highly competitive ... and constant development in technology. In 2014, government ...
(Date:2/25/2015)... 25, 2015  ABC Financial Services (ABC), the ... Health and Fitness Industry, today announced enhancements to ... The latest upgrade includes advances to the agreement ... check-in via Identity One fingerprint biometrics. The features ... interactive displays at the International Health, Racquet & ...
Breaking Biology News(10 mins):Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3
(Date:3/30/2015)... -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT; NASDAQ: ... Yale University, on March 27 released pre-clinical data on ... an oral presentation by Professor Gil Mor ... nd Annual Scientific Meeting of the Society of ... In both in vitro and in ...
(Date:3/30/2015)... March 30, 2015  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today ... No. 3:13-cv-03494-M and  Spherix v. Uniden , Case ... Court for the Northern District of ... Spherix v. Verizon, Case No. 1:14-cv-00721-GBL-TCB, in ...
(Date:3/30/2015)... Richmond Pharmacology nimmt weltweit ... ist das erste Zentrum weltweit, das in Zusammenarbeit ... in London in einer ... an einem Patienten begonnen hat. Das Therapeutikum wurde ... (ATTR), einer seltenen Herz- und Nervenkrankheit. ...
(Date:3/29/2015)... IRVING, Texas , March 29, 2015 ... the presentation of important study data showing ... cells in 1,599 gynecologic cancer samples. Using ... tumor profiling service, researchers identified expression of ... gynecologic cancers independent of histology while its ...
Breaking Biology Technology:Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4
Cached News: